Drugs / 2012/13 Seasonal Influenza Trivalent Inactivated Vaccine
last change Jul 2013 re-read 3 minutes ago

2012/13 Seasonal Influenza Trivalent Inactivated Vaccine

also known as TIV

Vaccine

Developed for
influenza
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID) · The Emmes Company, LLC

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01609998 Jun 2012 → Jul 2013 influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as 2012/13 Seasonal Influenza Trivalent Inactivated Vaccine “2012/13 Seasonal Influenza Trivalent Inactivated Vaccine” NCT01609998 ↗
Known as TIV ClinicalTrials.gov intervention name — accepted as the source's own label NCT01609998 ↗
Modality Vaccine “2012/13 Seasonal Influenza Trivalent Inactivated Vaccine (TIV)” NCT01609998 ↗